Search Team

Search by Last Name
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
 

Background

​Jack Brennan is a Principal in the New York* office of Fish & Richardson. His practice emphasizes patent prosecution, opinions, due diligence, and client counseling in the fields of biotechnology and pharmaceuticals. Dr. Brennan’s doctoral research involved identification and characterization of cell surface receptors used by natural killer cells to identify target cells.

*Not admitted to practice in New York – practice in New York limited to federal courts and agencies listed below or otherwise authorized by law.

Education

J.D., Boston University School of Law 1999
Boston University Law Review
magna cum laude


Ph.D., University of British Columbia 1996
Genetics


B.S., University of Dayton 1990
Biology

Admissions

  • U.S. Patent and Trademark Office 2001
  • Massachusetts 1999

Other Distinctions

Recognized as "IAM Patent 1000 – The World’s Leading Patent Professionals" (2016). ​​

Selected publications
"Timing of PTO Disclosures – A Trap for the Unwary," Ahmed Davis, Jack Brennan, Pharmaceutical Compliance Monitor (December 20, 2013).

"Adjusting the life of a US patent due to Patent Office delay," Cherylyn Esoy Mizzo, Jack Brennan, John B. Pegram, Industrial Biotechnology (February 2010), 6(1): 18-21.

Brennan "A state based right to physician assisted suicide," B.U.L. Rev. 79:231 (1999).

Brennan et al. "Heterogeneity among Ly-49C natural killer (NK) cells: Characterization of highly related receptors with differing functions and expression patterns," J. Exp. Med. 184:2085 (1996).

Brennan et al. "Recognition of class I major histocompatibility complex molecules by Ly-49: specificities and domain interactions," J. Exp. Med. 183:1553 (1996).

Brennan et al. "Carbohydrate recognition by a natural killer cell receptor, Ly-49C," J. Biol. Chem. 270:9691 (1995).

Brennan et al. "Expression of different members of the Ly-49 gene family defines distinct natural killer cell subsets and cell adhesion properties," J. Exp. Med. 180:2287 (1994).

What's trending with Jack

Filter by
News
June 15, 2016
Fish & Richardson Named to IAM Patent 1000 for National Patent Litigation and Prosecution Practices
Press Release
News
July 1, 2015
Fish & Richardson Named to IAM Patent 1000 for National Patent Prosecution and Litigation Practices
Press Release
Event
December 9th, 2009 | 12:00 pm EST
23rd Annual Pharmaceutical / Chemical Patent Practice Update
Speaking Engagement
Event
March 28th, 2012
Recent Developments in Patent Term Adjustments and Extensions
Speaking Engagement
Event
January 21st, 2010 | 2:00 pm EST
Patent Term Adjustment - What to do now, what to expect in the future
Speaking Engagement
Event
August 5th, 2010 | 2:00 pm EDT
Patent Term Extension: The Next Chapter
Speaking Engagement
Event
May 25th, 2011 | 8:00 am EDT
Recent Developments in Patent Term Adjustment Practice and Strategies for Maximizing PTA
Speaking Engagement
Event
August 18th, 2010 | 2:30 pm EDT
The Life Sciences Lawyer's Guide to Patent Term Adjustment and Patent Term Extensions
Speaking Engagement
News
July 1, 2014
Fish & Richardson Named to IAM Patent 1000
Press Release
News
December 20, 2013
Timing of PTO Disclosures – A Trap for the Unwary
Articles
News
June 13, 2013
Fish Named to IAM Patent 1000 for National Patent Prosecution and Litigation Practices
Media Mention
Articles
News
September 21, 2012
Client Alert: Patent Term Adjustment: The New USPTO Rules
Articles
load more topics